XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Compensation Expense

The following table summarizes restricted stock compensation expense for the three months ended March 31, 2022 and 2021:

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Total share-based compensation - restricted stock

 

$

1,264

 

 

$

783

 

Income tax benefit

 

 

343

 

 

 

218

 

Unrecognized compensation expense

 

 

13,525

 

 

 

9,720

 

Weighted-average amortization period remaining

 

2.9 years

 

 

2.7 years

 

Omnibus Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Changes in Restricted Shares

The following table discloses the changes in restricted shares for the three months ended March 31, 2022:

 

 

 

Omnibus Plan

 

 

 

Number of Shares

 

 

Weighted Average
Grant Date Fair
Value

 

Beginning balance, January 1, 2022

 

 

542,520

 

 

$

19.04

 

Granted

 

 

289,277

 

 

 

26.97

 

Vested

 

 

(75,171

)

 

 

18.47

 

Forfeited

 

 

(169

)

 

 

18.33

 

Ending balance outstanding at March 31, 2022

 

 

756,457

 

 

$

22.13

 

BYB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options and the weighted average exercise prices, in actual dollars, for the three months ended March 31, 2022:

 

 

 

BYB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic
Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2022

 

 

1,337,048

 

 

$

11.26

 

 

$

21,519

 

 

 

3.5

 

Exercised

 

 

(256,494

)

 

 

11.18

 

 

$

4,054

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at March 31, 2022

 

 

1,080,554

 

 

$

11.27

 

 

$

16,647

 

 

 

3.2

 

Exercisable at March 31, 2022

 

 

1,080,554

 

 

$

11.27

 

 

$

16,647

 

 

 

3.2

 

FEB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the three months ended March 31, 2022:

 

 

 

FEB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic
Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2022

 

 

170,697

 

 

$

11.60

 

 

$

2,688

 

 

 

3.4

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at March 31, 2022

 

 

170,697

 

 

$

11.60

 

 

$

2,574

 

 

 

3.1

 

Exercisable at March 31, 2022

 

 

170,697

 

 

$

11.60

 

 

$

2,574

 

 

 

3.1